Position in EDIT
as of Mar 31, 2026
· filed Apr 15, 2026
Position Value
$1,235
+$210 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TRUST CO OF TOLEDO NA /OH/ holds $1,850,012 across 14 Biotechnology names. EDIT ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TRVI |
Trevi Therapeutics, Inc.
|
131,502 | $1,568,818 | |
| 2 | LCTX |
Lineage Cell Therapeutics, Inc.
|
83,795 | $132,396 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
245 | $109,402 | |
| 4 | CRDF |
Cardiff Oncology, Inc.
|
9,000 | $14,580 | |
| 5 | ATYR |
aTYR PHARMA INC
|
16,640 | $12,979 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8 | $6,181 | |
| 7 | CRMD |
CorMedix Inc.
|
360 | $2,444 | |
| 8 | EDIT |
Editas Medicine, Inc.
This page
|
500 | $1,235 |
All Filings in EDIT
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,235 | 500 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $1,025 | 500 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,735 | 500 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,100 | 500 | Shares | Sole | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||